Natalie Joe, Ph.D.

Natalie Joe
Natalie Joe, Ph.D.
Entry Year

Doctoral Degree

Ph.D., Cellular and Molecular Medicine, Johns Hopkins University School of Medicine (2022)

Master's Degree

M.P.H., Johns Hopkins Bloomberg School of Public Health (2023)

Research Interests

Cancer Biology; Indigenous Health; Cancer Therapeutics; Cancer Epidemiology; Cancer Disparities; Women's Malignancies; Tribal Public Health Policy


Joe NS, Godet I, Milki N, Ain NUI, Oza HH, Riggins GJ, Gilkes DM. Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness. Breast Cancer Res. 2022 Dec 28;24(1):98. doi: 10.1186/s13058-022-01591-3. PMID: 36578038.

Lind NM, Joe NS, Newell BS, Morris AM. High Yielding, One-Pot Synthesis of Bis(1H-indazol-1-yl)methane Catalyzed by 3d-Metal Salts. Reactions (Basel). 2022 Mar;3(1):59-69. doi: 10.3390/reactions3010005. Epub 2022 Jan 4. PMID: 35072056.

Joe NS, Hodgdon C, Kraemer L, Redmond KJ, Stearns V, Gilkes DM. A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases. NPJ Breast Cancer. 2021 Sep 14;7(1):121. doi: 10.1038/s41523-021-00326-5. PMID: 34521857.

Williamson T, Mendes TB, Joe N, Cerutti JM, Riggins GJ. Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer. Endocr Relat Cancer. 2020 Mar;27(3):123-136. doi: 10.1530/ERC-19-0341. PMID: 31846433.